Repaglinide 135062-02-1
| Post Date: |
May 07,2019 |
| Expiry Date: |
Nov 03,2019 |
| Detailed Description: |
Cas No. :135062-02-1
Repaglinide is an antidiabetic drug in the class of medications known as meglitinides. It is an oral medication used in addition to diet and exercise for blood sugar control in type 2 diabetes mellitus. |
| CAS Registry Number: |
|
| Synonyms: |
;4-Ethoxycarbonyl-3-ethoxy phenyl acetic acid;(S)-(+)-2-Ethoxy-4-[N-[1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbonylmethyl]benzoic acid;2-ethoxy-4-[2-({3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl}amino)-2-oxoethyl]benzoic acid;2-ethoxy-4-[2-({(1S)-3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl}amino)-2-oxoethyl]benzoic acid; |
| Molecular Formula: |
C27H36N2O4 |
| Molecular Weight: |
452.5857 |
| Molecular Structure: |
|
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
